NEOVACS Alternatives & Competitors
12 companies similar to NEOVACS — Nous développons les thérapies de demain et investissons dans des sociétés innov...
Companies similar to NEOVACS
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Novelogics Biotechnology Inc.
Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer us...
Canada
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
MabGenesis Inc.
Discovery of innovative therapeutic antibodies for human and animal health
Yokohama, Japan
Track all NEOVACS competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Evelo Biosciences
Clinical stage biotech company developing a new modality of oral biologics that act on cel...
Cambridge, United States
ImmunGene
Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies...
Singapore, Singapore
Biotheus Inc.
To Inspire Each Other and Create Effective Medicines for Humankind
Zhuhai, China
Immutep Limited
The global leader in developing LAG-3 therapeutics (ASX: IMM, NASDAQ: IMMP)
Australia
MacroGenics, Inc.
Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious disea...
Rockville, United States
-logo.jpg "United Biomedical, Inc. (UBI)"){kind=logo}
United Biomedical, Inc. (UBI)
Pioneering the future of healthcare with innovative immunotherapeutics and vaccines for ch...
United States
Synthekine
Synthekine a biotechnology company focused on discovery and developing best in class cytok...
Menlo Park, United States
About NEOVACS
**NEOVACS** NEOVACS is a French Biotechnology company founded in 1993. Their mission is to develop therapeutic vaccines for the treatment of autoimmune and inflammatory diseases. Additionally, they invest in innovative companies within the Biotech and Medtech industries.
biotechnology research and development, drug development, investing in biotech and medtech companies
patients with lupus and allergies, biotech and medtech companies
Therapeutic Vaccines, Autoimmune Diseases, Inflammatory Diseases, Immunotherapy, Medtech, AIDS Treatment, Cancer Treatment, Polyclonal Antibody Response, Immunologist, Viral Proteins, Monoclonal Antibodies, Cytokine-related Diseases, Allergic Diseases
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches NEOVACS and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at NEOVACS on 7 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
